Abstract:To search the possibility of utilizing interleukin-15 (IL-15) in preparation of adherent human natural killer (A-NK) cells, recombinant human IL-15 (rhIL-15) or rhIL-2 (500 u/ml of each cytokine) were added to purified human NK cell culture in 24-well plastic plate. The cytokine-induced adherent ratio was calculated by percentage of A-NK cell in whole NK cells. The cytotoxicity of NK cells (NA- or A-NK cells) was examined by 4-h 51Chromium release assay, the surface markers of NK cells were checked by flow cytometry, and the cytokines were analyzed by reverse transcript (RT)-PCR and ELISA method. RhIL-15-induced adherence of human NK cells into plastic was higher than IL-2 when harvesting the A-NK cells at each hour point from hr 1 to hr 12. IL-15- and IL-2-induced adherent ratio peaked to 36.67% and 27.73% at hr 1, and the IL-15-induced adherent ratio was around two folds higher than IL-2-induced group at hrs 2, 3, 4, 5, 6, 7, and 8. The IL-15 group expanded more rapidly than IL-2 during 2 weeks' culture. IL-15- and IL-2-A-NK cells exerted similar levels of higher cytotoxic potentials. A-NK cells were characterized with phenotypes of CD3(-)CD16(+)CD56(+) (more than 93%) in the presence of IL-2 or IL-15 stimulation. CD54, an intracellular adhesion molecule (ICAM), was also continuously expressed in A-NK cells (more than 85%) induced by each cytokine. Interestingly, IL-15 stimulated relatively low level of expression of CD18, a beta2 integrin molecule related to lymphocyte apoptosis in A-NK cells (11.45%), whereas IL-2 exerted a strong effect on CD18 expression (87.54%). IL-11b was only expressed at A-NK cell induced by IL-2 (49.56%), IL-15 did not exert any stimulating effect on CD11b expression. All A-NK cells expressed high levels of interferon gamma (IFNgamma) after stimulation with IL-2 or IL-15. In contrast to IL-2, IL-15 did not stimulate gene expressions of type 2 cytokines (e.g. IL-4, IL-6, IL-10 and IL-13) in A-NK cells. The results indicate that rhIL15 is possibly a stronger stimulator for A-NK cell preparation by improving adherence and proliferation through inhibiting apoptosis by down-regulating the expression of CD18 and type 2 cytokines.

Evaluation of the Antitumor Activity of Human IL-4 by in Vitro and in Vivo Assays.

Activity of Recombinant Human Interleukin-15 Against Tumor Recurrence and Metastasis in Mice

Effect of human rIL-2 on tumor cytotoxicity murine splenic cells

Synergistic effects of IL-2 and IL-12 on antitumor activity of human PBMC in vitro

Administration of recombinant IL-4 to humans regulates gene expression, phenotype, and function in circulating monocytes.

Research progress of IL-4/IL-4R and tumor

Effects of Rhctla4ig on Human T Lymphocyte in Vitro

The Humoral Antitumor Responses Induced by IL-4 Gene-Modified Tumor Vaccine

[Interleukin-2 Improves the Antitumor Activity of Rituximab in Patients with B-cell Lymphoma in Vitro].

Toxicology, pharmacokinetics, and immunogenicity studies of CCR4-IL2 bispecific immunotoxin in rats and minipigs

Antitumor activities of subsets of human IL-2-activated natural killer cells in solid tissues.

Optimization on Expression of Recombinant Human Interleukin 21 and Its Biological Activity Analysis In Vitro

Effects of Interleukin-4 and Granulocyte Macrophage-Colony Stimulating Factor on Proliferation and Cytotoxicity of Tumor Infiltrating Lymphocytes

Preliminary Study on Mouse Interleukin-21 Application in Tumor Gene Therapy.

Effect of recombinant human IL-21 on the human peripheral blood mononuclear cell

The antibody-based targeted delivery of interleukin-4 and 12 to the tumor neovasculature eradicates tumors in three mouse models of cancer

EXPERIMENTAL STUDY ON INTERLEUKIN-6 ACTIVITY AGAINST TUMOR: REGULATION OF INTERLEUKIN-2- INDUCED LAK CELL ACTIVITY

Use of Interleukin-15 for Preparation of Adherent NK Cells from Human Peripheral Blood: Comparison with Interleukin-2.

Regulatory Effect of Interleukin-4 in the Innate Inflammatory Response to Rhodococcus Aurantiacus Infection in Mice.

[IL-4 Gene Transfer Induces the Differentiation of Cells and Inhibits the Activity of Telomerase in Hepatoblastoma Cells].

Comparison of the in vitro and in vivo antitumor activities of tumor-draining lymph node lymphocytes and lymphokine-activated killer cells from human oral cancer